1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > PharmaPoint: Asthma - Current and Future Players

PharmaPoint: Asthma - Current and Future Players

  • August 2014
  • -
  • Global Data
  • -
  • 55 pages

PharmaPoint: Asthma - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Asthma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Asthma Market. The report identifies and analyses the key companies shaping and driving the global Asthma market. The report provides insight into the competitive Asthma landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Asthma
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Asthma sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Asthma market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Asthma market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Asthma - Current and Future Players
1 Table of Contents

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers - Global Issues 18
4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 24
4.3.1 GlaxoSmithKline 24
4.3.2 Merck and Co. 27
4.3.3 AstraZeneca/MedImmune 30
4.3.4 Novartis 32
4.3.5 Roche/Genentech 35
4.3.6 Teva 37
4.3.7 Boehringer Ingelheim 40
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 44
5.3 Methodology 46
5.4 Forecasting Methodology 46
5.4.1 Diagnosed Asthma Patients 46
5.4.2 Percent Drug-Treated Patients 47
5.4.3 General Pricing Assumptions 47
5.4.4 Generic Erosion 48
5.5 Physicians and Specialists Included in This Study 49
5.6 About the Authors 52
5.6.1 Author 52
5.6.2 Author/Reviewer 52
5.6.3 Reviewer 53
5.6.4 Global Head of Healthcare 53
5.7 About GlobalData 54
5.8 Disclaimer 54

1.1 List of Tables

Table 1: Global Sales Forecast ($m) for Asthma, 2013-2023 14
Table 2: Global Asthma Market - Drivers and Barriers, 2014 18
Table 3: Key Companies in the Asthma Market, 2014 22
Table 4: GSK's Asthma Portfolio Assessment, 2014 26
Table 5: GSK SWOT Analysis, 2013 27
Table 6: Merck's Asthma Portfolio Assessment, 2014 29
Table 7: Merck SWOT Analysis, 2012 29
Table 8: AstraZeneca's Portfolio Assessment, 2014 31
Table 9: AstraZeneca SWOT Analysis, 2014 32
Table 10: Novartis' Asthma Portfolio Assessment, 2014 34
Table 11: Novartis SWOT Analysis, 2012 35
Table 12: Roche/Genentech's Portfolio Assessment, 2014 36
Table 13: Roche/Genentech SWOT Analysis, 2014 37
Table 14: Teva's Portfolio Assessment, 2014 39
Table 15: Teva SWOT Analysis, 2014 40
Table 16: Boehringer Ingelheim's Portfolio Assessment, 2014 42
Table 17: Boehringer Ingelheim SWOT Analysis, 2014 42
Table 18: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 51

1.2 List of Figures

Figure 1: Global Sales for Asthma by Region, 2013-2023 17
Figure 2: Company Portfolio Gap Analysis in Asthma, 2013-2023 23

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Asthma and COPD Drugs Market - U.S. and China Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Asthma and COPD Drugs Market - U.S. and China Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

U.S. and China Asthma and COPD Drugs Market: Overview Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell ...

Asthma - Market Insights, Epidemiology and Market Forecast-2023

Asthma - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Asthma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.